NSC | Compound | Enrichment | Correlation |
---|---|---|---|
NSC 682582 | Null | 0.0352028253287043 | 0.4492321 |
NSC 699092 | Null | 0.0352028253287043 | -0.40066152 |
NSC 706031 | Null | 0.0352028253287043 | -0.23957793 |
NSC 718530 | Null | 0.0352028253287043 | -0.34033046 |
NSC 724784 | (1S,4R,5R,8R,12R,13S)-1,5-dimethyl-9-methylene-11,14,15,16-t etraoxatetracyclo[10.3.1.04,13.08,13]hexadec-10-yl]oxy}-3-he xenyl)oxy]-1,5,-dimethyl-9-methylene-11,14,15,16-tetraoxatet racyclo[10.3.1.0 | 0.0352028253287043 | -0.38859587 |
NSC 763587 | Null | 0.0352028253287043 | -0.52147186 |
NSC 157381 | Null | 0.0366216145653012 | -0.22226641 |
NSC 263637 | 4H-[1]Benzopyrano[2,3-d]pyrimidin-4-one, 2,3-dihydro-2-phenyl- | 0.0366216145653012 | -0.18853139 |
NSC 287459 | Cytarabine AY | 0.0366216145653012 | -0.2606495 |
NSC 630004 | 1,4-Hydroquinone-2-methoxy-5-dimethylaminomethyl-6-(10-heptadecenyl)-(Z)-, hydrochloride | 0.0366216145653012 | -0.13684725 |